TY - JOUR
T1 - Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
AU - Foley, Bree
AU - Cooley, Sarah
AU - Verneris, Michael R
AU - Pitt, Michelle
AU - Curtsinger, Julie
AU - Luo, Xianghua
AU - Lopez-Vergès, Sandra
AU - Lanier, Lewis L
AU - Weisdorf, Daniel
AU - Miller, Jeffrey S
PY - 2012/3/15
Y1 - 2012/3/15
N2 - During mouse cytomegalovirus (CMV) infection, a population of Ly49H(+) natural killer (NK) cells expands and is responsible for disease clearance through the induction of a "memory NK-cell response." Whether similar events occur in human CMV infection is unknown. In the present study, we characterized the kinetics of the NK-cell response to CMV reactivation in human recipients after hematopoietic cell transplantation. During acute infection, NKG2C(+) NK cells expanded and were potent producers of IFNγ. NKG2C(+) NK cells predominately expressed killer cell immunoglobulin-like receptor, and self-killer cell immunoglobulin-like receptors were required for robust IFNγ production. During the first year after transplantation, CMV reactivation induced a more mature phenotype characterized by an increase in CD56(dim) NK cells. Strikingly, increased frequencies of NKG2C(+) NK cells persisted and continued to increase in recipients who reactivated CMV, whereas these cells remained at low frequency in recipients without CMV reactivation. Persisting NKG2C(+) NK cells lacked NKG2A, expressed CD158b, preferentially acquired CD57, and were potent producers of IFNγ during the first year after transplantation. Recipients who reactivated CMV also expressed higher amounts of IFNγ, T-bet, and IL-15Rα mRNA transcripts. Our findings support the emerging concept that CMV-induced innate memory-cell populations may contribute to malignant disease relapse protection and infectious disease control long after transplantation.
AB - During mouse cytomegalovirus (CMV) infection, a population of Ly49H(+) natural killer (NK) cells expands and is responsible for disease clearance through the induction of a "memory NK-cell response." Whether similar events occur in human CMV infection is unknown. In the present study, we characterized the kinetics of the NK-cell response to CMV reactivation in human recipients after hematopoietic cell transplantation. During acute infection, NKG2C(+) NK cells expanded and were potent producers of IFNγ. NKG2C(+) NK cells predominately expressed killer cell immunoglobulin-like receptor, and self-killer cell immunoglobulin-like receptors were required for robust IFNγ production. During the first year after transplantation, CMV reactivation induced a more mature phenotype characterized by an increase in CD56(dim) NK cells. Strikingly, increased frequencies of NKG2C(+) NK cells persisted and continued to increase in recipients who reactivated CMV, whereas these cells remained at low frequency in recipients without CMV reactivation. Persisting NKG2C(+) NK cells lacked NKG2A, expressed CD158b, preferentially acquired CD57, and were potent producers of IFNγ during the first year after transplantation. Recipients who reactivated CMV also expressed higher amounts of IFNγ, T-bet, and IL-15Rα mRNA transcripts. Our findings support the emerging concept that CMV-induced innate memory-cell populations may contribute to malignant disease relapse protection and infectious disease control long after transplantation.
KW - Biomarkers/metabolism
KW - Blotting, Western
KW - CD57 Antigens/metabolism
KW - Cohort Studies
KW - Cytomegalovirus/immunology
KW - Cytomegalovirus Infections/immunology
KW - Hematopoietic Stem Cell Transplantation
KW - Humans
KW - Interferon-gamma/metabolism
KW - Killer Cells, Natural/immunology
KW - NK Cell Lectin-Like Receptor Subfamily C/immunology
KW - RNA, Messenger/genetics
KW - Real-Time Polymerase Chain Reaction
KW - Receptors, KIR/genetics
KW - Receptors, KIR2DL2/genetics
KW - Receptors, KIR2DL3/genetics
KW - Transplantation, Homologous
KW - Virus Replication
UR - http://www.scopus.com/inward/record.url?scp=84863338121partnerID=8YFLogxK
U2 - 10.1182/blood-2011-10-386995
DO - 10.1182/blood-2011-10-386995
M3 - Article
C2 - 22180440
VL - 119
SP - 2665
EP - 2674
JO - Blood
JF - Blood
SN - 0006-4971
IS - 11
ER -